NewAmsterdam Pharma Co NV (STU:KH6)
€ 23.92 +0.22 (+0.93%) Market Cap: 2.90 Bil Enterprise Value: 2.35 Bil PE Ratio: 0 PB Ratio: 5.21 GF Score: 38/100

NewAmsterdam Pharma Company NV at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 03:30 PM GMT
Release Date Price: €26.2 (-6.43%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NAMS.OQ - NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV at TD Cowen Healthcare Conference
Mar 03, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone. Tyler Van Buren here, senior biotech analyst at TD Cowan.

Thank you very much for joining TD Cowan's 46th annual healthcare conference for our next session. Very excited to be hosting New Amsterdam. We have a hybrid presentation and fireside style chat Q&A. And it's my, pleasure to introduce Doctor Michael Davidson, New Amsterdam CEO and co-founder, and also Ian Samaya, the Chief Financial Officer. So with that, thank you very much for joining us. I'll hand it over to you, Michael, to get the presentation started.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot